{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:55:31Z","timestamp":1780491331607,"version":"3.54.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,24]]},"DOI":"10.7759\/cureus.25295","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T16:58:24Z","timestamp":1653411504000},"source":"Crossref","is-referenced-by-count":7,"title":["COVID-19 Vaccine: A Possible Trigger for Pyoderma Gangrenosum"],"prefix":"10.7759","author":[{"given":"Ahmed  B","family":"Mohd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar B","family":"Mohd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem A","family":"Ghannam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H","family":"Al-thnaibat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/v13101916","article-title":"Identification, mechanism, and treatment of skin lesions in COVID- 19: a review","volume":"13","author":"Fern\u00e1ndez-L\u00e1zaro D","year":"2021","unstructured":"Fern\u00e1ndez-L\u00e1zaro D, Garrosa M. Identification, mechanism, and treatment of skin lesions in COVID- 19: a review. Viruses. 2021, 13:1916. 10.3390\/v13101916","journal-title":"Viruses"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22625","article-title":"Recurrence of pyoderma gangrenosum potentially triggered by COVID-19 vaccination","volume":"14","author":"Clark AL","year":"2022","unstructured":"Clark AL, Williams B. Recurrence of pyoderma gangrenosum potentially triggered by COVID-19 vaccination. Cureus. 2022, 14:e22625. 10.7759\/cureus.22625","journal-title":"Cureus"},{"key":"ref3","unstructured":"Recent advances in managing and understanding pyoderma gangrenosum. (2019). Accessed. March 15, 2022: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6913206\/#ref-15."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.19-3-224","article-title":"Pyoderma gangrenosum - a guide to diagnosis and management","volume":"19","author":"George C","year":"2019","unstructured":"George C, Deroide F, Rustin M. Pyoderma gangrenosum - a guide to diagnosis and management\u2002. Clin Med (Lond). 2019, 19:224-8. 10.7861\/clinmedicine.19-3-224","journal-title":"Clin Med (Lond)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314550227","article-title":"Pyoderma gangrenosum and systemic lupus erythematosus: a report of five cases and review of the literature","volume":"24","author":"Gonz\u00e1lez-Moreno J","year":"2015","unstructured":"Gonz\u00e1lez-Moreno J, Ru\u00edz-Ruigomez M, Callejas Rubio JL, R\u00edos Fern\u00e1ndez R, Ortego Centeno N. Pyoderma gangrenosum and systemic lupus erythematosus: a report of five cases and review of the literature. Lupus. 2015, 24:130-7. 10.1177\/0961203314550227","journal-title":"Lupus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts","volume":"154","author":"Maverakis E","year":"2018","unstructured":"Maverakis E, Ma C, Shinkai K, et al.. Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts. JAMA Dermatol. 2018, 154:461-6. 10.1001\/jamadermatol.2017.5980","journal-title":"JAMA Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2021.05.016","article-title":"COVID-19 vaccines and the skin: the landscape of cutaneous vaccine reactions worldwide","volume":"39","author":"Sun Q","year":"2021","unstructured":"Sun Q, Fathy R, McMahon DE, Freeman EE. COVID-19 vaccines and the skin: the landscape of cutaneous vaccine reactions worldwide. Dermatol Clin. 2021, 39:653-73. 10.1016\/j.det.2021.05.016","journal-title":"Dermatol Clin"},{"key":"ref8","unstructured":"Covid-19 vaccine BNT162B1 elicits human antibody and th1 T cell responses. (2020). Accessed. March 15, 2022: https:\/\/www.nature.com\/articles\/s41586-020-2814-7."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17221","article-title":"Lichen planus arising after COVID-19 vaccination","volume":"35","author":"Hiltun I","year":"2021","unstructured":"Hiltun I, Sarriugarte J, Mart\u00ednez-de-Espronceda I, Garc\u00e9s A, Llanos C, Vives R, Yanguas JI. Lichen planus arising after COVID-19 vaccination. J Eur Acad Dermatol Venereol. 2021, 35:e414-5. 10.1111\/jdv.17221","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref10","article-title":"The interplay between inflammatory pathways and covid- 19: A critical review on pathogenesis and therapeutic options. Microbial Pathogenesis","author":"Choudhary","unstructured":"Choudhary, S., Sharma, K., & Silakari, O. (2020, December 2. The interplay between inflammatory pathways and covid- 19: A critical review on pathogenesis and therapeutic options. Microbial Pathogenesis. Accessed: March 15, 2022, from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0882401020310391."},{"key":"ref11","unstructured":"Jak-STAT signaling pathway in pyoderma gangrenosum - full text view. Full Text View - ClinicalTrials.gov. (n.d.). Retrieved. Accessed. March 15, 2022, from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04792957."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17744","article-title":"Cutaneous findings following COVID-19 vaccination: review of world literature and own experience","volume":"36","author":"Gambichler T","year":"2022","unstructured":"Gambichler T, Boms S, Susok L, et al.. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol. 2022, 36:172-80. 10.1111\/jdv.17744","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref13","article-title":"Pyoderma Gangrenosum","author":"Schmieder SJ","year":"2021","unstructured":"Schmieder SJ, Krishnamurthy K. Pyoderma Gangrenosum. StatPearls, Treasure Island, FL; 2021."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10010087","article-title":"Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy Adult","volume":"10","author":"Barry M","year":"2022","unstructured":"Barry M, AlRajhi A, Aljerian K. Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy Adult. Vaccines (Basel). 2022, 10:10.3390\/vaccines10010087","journal-title":"Vaccines (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/93282-covid-19-vaccine-a-possible-trigger-for-pyoderma-gangrenosum","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:48Z","timestamp":1707507828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/93282-covid-19-vaccine-a-possible-trigger-for-pyoderma-gangrenosum"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.25295","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,24]]}}}